Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicenter retrospective observational study.
Assaraf M, Chevet B, Wendling D, Philippe P, Cailliau E, Roux C, Avouac J, Delacour M, Houvenagel E, Sellam J, Cortet B, Henry J, Flipo RM, Devauchelle-Pensec V. Assaraf M, et al. Among authors: avouac j. Rheumatology (Oxford). 2023 Aug 21:kead426. doi: 10.1093/rheumatology/kead426. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37603729
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry.
Faganello D, Bertrand A, Meunier P, Avouac J, Toussirot E, Coury F, Seror R, Le Mélédo G, Germain V, Dellal A, Shima D, Hulin C, Prati C, Schaeverbeke T, Richez C, Truchetet ME, Kostine M. Faganello D, et al. Among authors: avouac j. Rheumatology (Oxford). 2024 Mar 1;63(3):787-790. doi: 10.1093/rheumatology/kead187. Rheumatology (Oxford). 2024. PMID: 37540112
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases.
Avouac J, Fogel O, Hecquet S, Daien C, Elalamy I, Picard F, Prati C, Salmon JH, Truchetet ME, Sellam J, Molto A; behalf of the French Society of Rheumatology. Avouac J, et al. Joint Bone Spine. 2023 Sep;90(5):105592. doi: 10.1016/j.jbspin.2023.105592. Epub 2023 May 16. Joint Bone Spine. 2023. PMID: 37201575 Free article.
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection.
Comarmond C, Drumez E, Labreuche J, Hachulla E, Thomas T, Flipo RM, Seror R, Avouac J, Balandraud N, Desbarbieux R, Felten R, Gilson M, Guyot MH, Hittinger-Roux A, Pham T, Renard M, Roux N, Sobanski V, Tournadre A, Richez C, Cacoub P; FAI2 R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Comarmond C, et al. Among authors: avouac j. J Transl Autoimmun. 2023 Jan 14;6:100190. doi: 10.1016/j.jtauto.2023.100190. eCollection 2023. J Transl Autoimmun. 2023. PMID: 36684808 Free PMC article.
Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600 mg.
Touret F, Martin-Blondel G, de Lamballerie X, Dupont A, Izopet J, Mentré F, Kamar N, Autran B, Paintaud G, Caillard S, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Yazdanpanah Y, N'Guyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Kali S, Angoulvant D, Barthélémy K, Priet S, Nurtop E, Sanchez VP, Tardivon C, Blancho G, Le Bourgeois A, Lévy V. Touret F, et al. Among authors: avouac j. J Infect. 2023 May;86(5):e126-e129. doi: 10.1016/j.jinf.2023.02.002. Epub 2023 Feb 5. J Infect. 2023. PMID: 36750165 No abstract available.
289 results